Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Nivolumab 3 / Ipilimumab 1 - Nivolumab 240, Renal Cell Carcinoma, maintenance

Protocol-ID: 1139 V1.1 (Mini), NIVO3/IPIL1 - NIVO240, RCC, maint.

Indication(s)

  • Renal Cell Carcinoma; ICD-10 C64
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 03.02.2023